Does anti-mutated citrullinated vimentin have additional value as a serological marker in the diagnostic and prognostic investigation of patients with rheumatoid arthritis? A systematic review

@article{Luime2010DoesAC,
  title={Does anti-mutated citrullinated vimentin have additional value as a serological marker in the diagnostic and prognostic investigation of patients with rheumatoid arthritis? A systematic review},
  author={J. Luime and E. Colin and J. Hazes and E. Lubberts},
  journal={Annals of the Rheumatic Diseases},
  year={2010},
  volume={69},
  pages={337 - 344}
}
  • J. Luime, E. Colin, +1 author E. Lubberts
  • Published 2010
  • Medicine
  • Annals of the Rheumatic Diseases
  • Objective: To review the diagnostic and prognostic value of anti-mutated citrullinated vimentin (MCV) in rheumatoid arthritis, taking into account the already available serology. Methods: Medline was searched via PubMed (1966 to May 2008) for anti-MCV and related terms, arthritis and arthropathies. Studies with anti-MCV, arthritis/arthropathy, and primary data on diagnosis and/or prognosis were included. Their methodological quality was assessed using the Quality Assessment of Diagnostic… CONTINUE READING
    74 Citations

    Paper Mentions

    Observational Clinical Trial
    The aim of this work is to evaluate the diagnostic value of anti-MCV antibodies in rheamatoid arthritis patients and to correlate its relationtion disease activity and manifestations… Expand
    ConditionsAnti-MCV in Rheamatoid Arthritis
    InterventionDiagnostic Test

    References

    SHOWING 1-10 OF 77 REFERENCES
    Antibodies to mutated citrullinated vimentin and disease activity score in early arthritis: a cohort study
    • 85
    • Highly Influential